Targeting ribosome biogenesis as a novel therapeutic approach to overcome EMT-related chemoresistance in breast cancer is a research paper published in eLife (2023). On theSindex it has a DataRank of 0.542. It has been cited 9 times, with 9 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.345
From this paper's citation signal
Citation Network Contribution
0.197
From 7 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 9 citers.
National Cancer Institute
Grant: R01CA244413
National Cancer Institute
Grant: R01 CA205418
National Institutes of Health
Grant: 1R01CA205418-01
Targeting the epithelial to mesenchymal transition-mediated chemoresistance in breast cancer
National Institutes of Health
Grant: 1R01CA244413-01A1
To study the EMT contributions in tumor metastasis and chemoresistance by using lineage tracing models
Fields of Study
MeSH Terms
Keywords